Matt Hancock Britain virus vaccine Matt Hancock Britain

UK: New study vindicates delaying 2nd virus vaccine dose

Reading now: 589
www.clickorlando.com

LONDON – Britain’s health chief says a new study showing that a single dose of the COVID-19 vaccine developed by Oxford University and AstraZeneca provides a high level of protection for 12 weeks supports the government’s strategy of delaying the second shot so more doses can be delivered to more people.

Health Secretary Matt Hancock's comments came after Oxford released a study showing the vaccine cut transmission of the virus by two-thirds and prevented severe disease.

The study has not been peer-reviewed yet, but it was greeted with excitement by U.K. officials under pressure to justify their decision to delay the second dose. “That reduction in transmission, as well as the fact there is no hospitalizations, the combination of that is

Read more on clickorlando.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA